600079 ST人福医药
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)10.1567.67113.30717.75311.168
总资产报酬率 ROA (%)5.0663.6585.9106.9553.884
投入资产回报率 ROIC (%)6.5824.7757.8039.1795.009

边际利润分析
销售毛利率 (%)48.21444.55345.80643.52542.747
营业利润率 (%)13.3469.91514.05615.74010.945
息税前利润/营业总收入 (%)14.02110.90415.03916.39813.608
净利润/营业总收入 (%)10.4026.99211.47913.7498.848

收益指标分析
经营活动净收益/利润总额(%)108.568114.31391.83972.56082.758
价值变动净收益/利润总额(%)3.69310.14510.15525.65614.445
营业外收支净额/利润总额(%)-4.626-4.094-1.872-2.626-3.501

偿债能力分析
流动比率 (X)1.8331.4891.4851.2831.167
速动比率 (X)1.5351.2211.2111.0570.966
资产负债率 (%)40.11243.32044.48650.19255.793
带息债务/全部投入资本 (%)29.42032.33534.21940.18848.946
股东权益/带息债务 (%)226.129195.060179.446138.82197.364
股东权益/负债合计 (%)128.321111.435105.82383.16665.548
利息保障倍数 (X)11.0827.90812.11215.4594.486

营运能力分析
应收账款周转天数 (天)139.676122.512114.800115.106110.763
存货周转天数 (天)100.10791.70795.33893.42188.484